Poland· PL-100195354
Szczepionka przeciwgruźlicza BCG 10
A tuberkulose, lebend abgeschwächt product containing vaccinum tuberculosis (bcg) cryodesiccatum szczepionka przeciw gruźlicy (bcg) liofilizowana, registered in Poland by Synthaverse S.A.. The same ATC class is registered in 7 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Tuberkulose, lebend abgeschwächt is registered in 7 of 19 countries.
Countries holding a registration under ATC J07AN01 (tuberkulose, lebend abgeschwächt), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 4 of them publish a price we can compare per daily dose
Tuberkulose, lebend abgeschwächt · ATC J07AN01
7 / 19 countries
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Vaccinum tuberculosis (BCG) cryodesiccatum Szczepionka przeciw gruźlicy (BCG) liofilizowana
- Manufacturer
- Synthaverse S.A.
- Country
- Poland (PL)
- ATC code
- J07AN01
- ATC class
- Tuberkulose, lebend abgeschwächt
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909990021017
- gtin05909990610198
- gtin05909990858637
- gtin05909990858644
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tuberkulose, lebend abgeschwächt in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsBCG vaccin AJV, 0,75 mg per ml, poeder en oplosmiddel voor suspensie voor injectieAJ Vaccines A/S
- SpainONCOTICE 2-8 X 10(8) UFC POLVO PARA SUSPENSION INTRAVESICALMerck Sharp & Dohme De Espana S.A.
- SwitzerlandBCG-medac
- FinlandBcg VaccineChiron Vaccines Limited
- United KingdomBCG-medac 1,600million units powder and solvent for suspension for instillation vials with conical adapter and catheterImported (Germany)
- NorwayOncoTICEMerck Sharp & Dohme B.V.
- CanadaVERITY-BCGVERITY PHARMACEUTICALS INC.
- SwedenOncoTICE 12,5 mg Pulver till lösning för intravesikal användningMerck Sharp & Dohme BV
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Austria · Bcg
- Bulgaria · Бцж Ваксина, Калгевакс
- Netherlands · Bm Onco Bcg
- Slovenia · Bcg
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2561f452-9bc7-4cb2-a73d-da04e16dcdbb GET /v1/drugs/2561f452-9bc7-4cb2-a73d-da04e16dcdbb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek i rozpuszczalnik do sporządzania zawiesiny do wstrzykiwań śródksórnych",
"source": "urpl",
"strength": "0,5 mg (od 1,5 mln do 6 mln żywych prątków BCG/ml); szczepionka 10 dawkowa, 1 dawka (0,1 ml)",
"packaging": "05909990021017 ¦ Rp ¦ 9785\n5 amp. proszku ¦ 5 amp. 1 ml rozp.\n05909990610198 ¦ Rp ¦ 33684\n1 amp. proszku ¦ 1 amp. 1 ml rozp.\n05909990858637 ¦ Rp ¦ 65713\n1 fiol. proszku ¦ 1 amp. 1 ml rozp.\n05909990858644 ¦ Rp ¦ 65714\n5 fiol. proszku ¦ 5 amp. 1 ml rozp.",
"substance": "Vaccinum BCG 0,5 mg (od 1,5 mln do 3 mln żywych prątków BCG/ml)",
"common_name": "Vaccinum tuberculosis (BCG) cryodesiccatum Szczepionka przeciw gruźlicy (BCG) liofilizowana",
"pl_product_id": "100195354",
"pozwolenie_nr": "00210",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about tuberkulose, lebend abgeschwächt.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.